Printer Friendly

BIOMEDevice is Medical OEM's "Last Chance" to See SYGNUS in 2010.

Europe is Next Stop for Implantable Contact System

SAN JOSE, Calif. -- U.S. medical device manufacturers and design engineers who want to see and touch the SYGNUS[TM] Implantable Contact System before the end of 2010 will have one final opportunity to do so at this week's BIOMEDevice show in San Jose, California.

During the show, which runs November 10th-11th at the McEnery Convention Center, global sealing, connecting and conducting solutions provider Bal Seal Engineering, Inc. will feature the new SYGNUS system in its exhibit, #1034. The company officially introduced SYGNUS to the medical market at MD&M Minneapolis in mid-October and says BIOMEDevice will be the product's last trade event stop until its European debut at MEDICA/COMPAMED in Germany later this month.

According to Bal Seal, SYGNUS is the "world's first integrated seal and contact system for active implantable devices." The system combines electrical contacts and isolation seals in a standardized, platform-ready stack configuration, offering a turnkey connecting solution for devices used in cardiac rhythm management, neuromodulation, and neuro sensing therapies.

Bal Seal says the system pairs its proven Bal Conn[TM] electrical contact technology with pre-tested silicone seals, resulting in an "all-inclusive package engineered to help large and small device OEMs improve speed to market, reduce overall device volume and eliminate the need for procurement and testing of individual components."

An eight-page technical catalog published by Bal Seal and available for download at www.sygnus.com indicates that the number of contacts and seals in the SYGNUS system is configurable to meet unique application and industry requirements, such as the IS-4 and DF-4 standards for cardiac health management devices. The Canted-coil[TM] spring contact design offers multi-point conductivity and low insertion force, and compensates for surface irregularities. The system's silicone seals provide superior dielectric isolation, and the combined stack offers excellent resistance to potential fatigue caused by multiple lead insertion cycles. Contacts in the stack are force and resistance tested, and sealing components are packaged to critical clean standards, the catalog states.

At BIOMEDevice 2010, Bal Seal will introduce the new SYGNUS[TM] Implantable Contact System to an expected audience of more than 10,000 attendees. The company will demonstrate the system's functionality using a variety of media, and it will urge medical device design engineers and OEMs to connect with SYGNUS and "connect with confidence."

Bal Seal Engineering, Inc. is a global provider of custom-engineered sealing, connecting, conducting and EMI shielding/grounding solutions for industry worldwide. The company's products employ unique Canted-coil[TM] spring technology for enhanced performance and reliability. For the latest news and information about Bal Seal, visit http://mediaroom.balseal.com or call 800.366.1006. For more information about the SYGNUS[TM] Implantable Contact System, visit www.sygnus.com
COPYRIGHT 2010 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2010 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1U9CA
Date:Nov 8, 2010
Words:516
Previous Article:Delaware Investments[R] Dividend and Income Fund, Inc. Announces Dividends.
Next Article:Delaware Investments[R] Municipal Income Funds Announce Dividends.
Topics:

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters